Field study of cyproheptadine/chloroquine synergism in falciparum malaria. 1990

A Björkman, and M Willcox, and C M Kihamia, and L F Mahikwano, and P A Howard, and A Häkansson, and D Warhurst

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D003533 Cyproheptadine A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc. Antergan,Dihexazin,Periactin,Peritol,Viternum
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

A Björkman, and M Willcox, and C M Kihamia, and L F Mahikwano, and P A Howard, and A Häkansson, and D Warhurst
March 1983, The New England journal of medicine,
A Björkman, and M Willcox, and C M Kihamia, and L F Mahikwano, and P A Howard, and A Häkansson, and D Warhurst
November 1968, Lancet (London, England),
A Björkman, and M Willcox, and C M Kihamia, and L F Mahikwano, and P A Howard, and A Häkansson, and D Warhurst
May 1980, The Medical journal of Australia,
A Björkman, and M Willcox, and C M Kihamia, and L F Mahikwano, and P A Howard, and A Häkansson, and D Warhurst
December 1967, JAMA,
A Björkman, and M Willcox, and C M Kihamia, and L F Mahikwano, and P A Howard, and A Häkansson, and D Warhurst
December 1967, JAMA,
A Björkman, and M Willcox, and C M Kihamia, and L F Mahikwano, and P A Howard, and A Häkansson, and D Warhurst
October 1978, The Medical journal of Australia,
A Björkman, and M Willcox, and C M Kihamia, and L F Mahikwano, and P A Howard, and A Häkansson, and D Warhurst
June 1967, JAMA,
A Björkman, and M Willcox, and C M Kihamia, and L F Mahikwano, and P A Howard, and A Häkansson, and D Warhurst
June 1979, The Medical journal of Australia,
A Björkman, and M Willcox, and C M Kihamia, and L F Mahikwano, and P A Howard, and A Häkansson, and D Warhurst
January 1979, The Medical journal of Australia,
A Björkman, and M Willcox, and C M Kihamia, and L F Mahikwano, and P A Howard, and A Häkansson, and D Warhurst
July 1979, The Medical journal of Australia,
Copied contents to your clipboard!